People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

44.48USD
28 Aug 2014
Price Change (% chg)

$-0.89 (-1.96%)
Prev Close
$45.37
Open
$45.04
Day's High
$45.54
Day's Low
$44.43
Volume
323,768
Avg. Vol
733,708
52-wk High
$54.25
52-wk Low
$29.36

Search Stocks

Breyer, Robert 

Brief Biography

Mr. Robert A. Breyer is an Independent Director of Alkermes Plc. From July 1994 to September 16, 2011, Mr. Breyer served on Alkermes' board of directors. He served as the President of Alkermes from July 1994 until his retirement in December 2001 and Chief Operating Officer from July 1994 to February 2001. Prior to that time, Mr. Breyer was an executive and held various positions in the global pharmaceutical and medical device industries, including in the United States, the Netherlands, Belgium and Italy. Mr. Breyer served on the board of directors of Lentigen, Inc., a privately held, diversified biology company from 2007 to 2009. Mr. Breyer's experience as an executive in the pharmaceutical and medical device industries provides management and operational skills to the board of directors.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

6,587,780

Shane Cooke

3,164,580

James Frates

1,831,190

Gordon Pugh

1,965,720

Kathryn Biberstein

2,113,310

Rebecca Peterson

--
As Of 30 Mar 2013
Search Stocks